Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.06 USD | -2.64% | -7.73% | -18.96% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 17.18M | Capitalization | 167M |
---|---|---|---|---|---|
Net income 2024 * | -56M | Net income 2025 * | -59M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 9.73 x |
P/E ratio 2024 * |
-2.99
x | P/E ratio 2025 * |
-2.6
x | Employees | 84 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.62% |
Latest transcript on Abeona Therapeutics Inc.
1 day | -2.64% | ||
1 week | -7.73% | ||
Current month | -1.93% | ||
1 month | +28.08% | ||
3 months | -41.83% | ||
6 months | -5.80% | ||
Current year | -18.96% |
Managers | Title | Age | Since |
---|---|---|---|
Vishwas Seshadri
CEO | Chief Executive Officer | 48 | 21-05-31 |
Michael Amoroso
CHM | Chairman | 46 | 20-07-08 |
Joseph Vazzano
DFI | Director of Finance/CFO | 40 | 22-03-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Alvino
BRD | Director/Board Member | 56 | 06-02-28 |
Faith Charles
BRD | Director/Board Member | 62 | 21-03-24 |
Leila Alland
BRD | Director/Board Member | 61 | 21-04-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 4.06 | -2.64% | 540,587 |
24-05-23 | 4.17 | -2.80% | 515,412 |
24-05-22 | 4.29 | -0.46% | 343,918 |
24-05-21 | 4.31 | -3.15% | 602,870 |
24-05-20 | 4.45 | +1.14% | 474,324 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.96% | 167M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- ABEO Stock